ResearcherVirginia Commonwealth UniversityNo recent work listed
Praveen Bhoopathi
Matched on ORCID iD 0000-0003-1379-4199; OpenAlex author ID A5005223730. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers
Papers 5
- Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy. Co-author DOI 10.1016/bs.acr.2023.02.010↗
- Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity. Co-author DOI 10.1136/jitc-2023-007624↗
- The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocarcinoma. Co-author DOI 10.1016/bs.acr.2015.04.009↗
- Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline. Co-author DOI 10.1158/0008-5472.can-14-3013↗
- Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid. Co-author DOI 10.1158/0008-5472.can-14-0819↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Paul B. Fisher · 5 shared papers, 2014–2023 · strength 0.52
- Paper Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy. DOI 10.1016/bs.acr.2023.02.010↗
- Paper Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by ac… DOI 10.1136/jitc-2023-007624↗
- Paper The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocar… DOI 10.1016/bs.acr.2015.04.009↗
- Luni Emdad · 5 shared papers, 2014–2023 · strength 0.52
- Paper Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy. DOI 10.1016/bs.acr.2023.02.010↗
- Paper Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by ac… DOI 10.1136/jitc-2023-007624↗
- Paper The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocar… DOI 10.1016/bs.acr.2015.04.009↗
- Rajan Gogna · 1 shared paper, 2023 · strength 0.15
- Vignesh Vudatha · 1 shared paper, 2023 · strength 0.15
- Esha Madan · 1 shared paper, 2023 · strength 0.15
- Jose Gilberto Trevino · 1 shared paper, 2023 · strength 0.15
- Azeddine Atfi · 1 shared paper, 2023 · strength 0.15
- Bridget A. Quinn · 3 shared papers, 2014–2015 · strength 0.14
- Paper The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocar… DOI 10.1016/bs.acr.2015.04.009↗
- Paper Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline. DOI 10.1158/0008-5472.can-14-3013↗
- Paper Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid. DOI 10.1158/0008-5472.can-14-0819↗
- Maurizio Pellecchia · 2 shared papers, 2015 · strength 0.10
- Siddik Sarkar · 1 shared paper, 2015 · strength 0.05
- Steven R. Grossman · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.